We are live on ! Find out more

458 hedge funds and large institutions have $5.6B invested in Chemours in 2017 Q1 according to their latest regulatory filings, with 92 funds opening new positions, 109 increasing their positions, 157 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

151% more call options, than puts

Call options by funds: $111M | Put options by funds: $44.3M

124% more first-time investments, than exits

New positions opened: 92 | Existing positions closed: 41

100% more funds holding in top 10

Funds holding in top 10: 612 (+6)

79% more capital invested

Capital invested by funds: $3.13B → $5.6B (+$2.47B)

10% more funds holding

Funds holding: 416458 (+42)

1% more ownership

Funds ownership: 78.04%79.04% (+1%)

31% less repeat investments, than reductions

Existing positions increased: 109 | Existing positions reduced: 157

Holders
458
Holders Change
+42
Holders Change %
+10.1%
% of All Funds
11.4%
Holding in Top 10
12
Holding in Top 10 Change
+6
Holding in Top 10 Change %
+100%
% of All Funds
0.3%
New
92
Increased
109
Reduced
157
Closed
41
Calls
$111M
Puts
$44.3M
Net Calls
+$66.6M
Net Calls Change
+$40.9M
Name Holding Trade Value Shares
Change
Change in
Stake
ASRS
126
Arizona State Retirement System
Arizona
$2.93M -$524K -17,400 -19%
EI
127
EAM Investors
California
$2.9M -$1.16M -38,641 -34%
SOMRS
128
State of Michigan Retirement System
Michigan
$2.86M +$2.24M +74,400 New
ICRM
129
Insight Capital Research & Management
California
$2.79M +$2.18M +72,506 New
GC
130
GMT Capital
Georgia
$2.69M -$52M -1,727,100 -96%
AIP
131
Ameritas Investment Partners
Nebraska
$2.67M +$1.62M +53,991 +349%
SPC
132
Sigma Planning Corp
Michigan
$2.67M +$2.09M +69,344 New
SO
133
STRS Ohio
Ohio
$2.66M -$313K -10,400 -13%
N
134
Nuveen
North Carolina
$2.61M +$1.21M +40,156 +146%
CCI
135
Credit Capital Investments
New Jersey
$2.5M +$1.96M +65,000 New
HHMI
136
Howard Hughes Medical Institute
Maryland
$2.48M -$1.39M -46,111 -42%
ZIM
137
Zacks Investment Management
Illinois
$2.38M +$1.31M +43,429 +235%
HTC
138
Haverford Trust Company
Pennsylvania
$2.38M +$105K +3,479 +6%
HS
139
HighVista Strategies
Massachusetts
$2.33M
SCM
140
SkyTop Capital Management
New Jersey
$2.31M +$1.81M +60,000 New
AIM
141
Alambic Investment Management
California
$2.25M -$928K -30,820 -34%
NIT
142
NumerixS Investment Technologies
British Columbia, Canada
$2.2M -$1.68M -55,708 -49%
Russell Investments Group
143
Russell Investments Group
United Kingdom
$2.13M -$830K -27,588 -33%
CIP
144
Convergence Investment Partners
Florida
$2.01M -$3.39M -112,705 -68%
EGM
145
Engineers Gate Manager
New York
$2M +$1.56M +51,887 New
AC
146
Ascend Capital
California
$1.95M +$1.53M +50,726 New
ProShare Advisors
147
ProShare Advisors
Maryland
$1.94M -$692 -23 -0%
BNP Paribas Financial Markets
148
BNP Paribas Financial Markets
France
$1.91M -$66.7K -2,216 -4%
GH
149
GAM Holding
Switzerland
$1.82M +$1.43M +47,406 New
PA
150
Profund Advisors
Maryland
$1.8M -$356K -11,836 -20%

CC Hedge Fund Activity: Q1 2017 in Review

458 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Chemours (CC) for Q1 2017, worth a combined $5.6B — up 79% from $3.13B a quarter earlier.

Buyers outnumbered sellers: 92 funds opened new CC positions and 41 closed out — a net gain of 51 holders — while 109 added to existing stakes and 157 trimmed.

The largest buyer was BlackRock, adding an estimated $575M. The largest seller was Greenlight Capital, cutting an estimated $119M.

  • 458 institutional investors held Chemours (CC) as of Q1 2017, up from 416 in Q4 2016.
  • Funds reported $5.6B of Chemours stock for Q1 2017, up 79% quarter-over-quarter.
  • 92 funds opened new Chemours positions in Q1 2017 and 41 closed out, a net change of +51 holders.
  • The largest Chemours buyer in Q1 2017 was BlackRock, an estimated $575M added.
  • The largest Chemours seller in Q1 2017 was Greenlight Capital, an estimated $119M sold.

Based on aggregated 13F filings for Q1 2017.